MARI, Rosella
 Distribuzione geografica
Continente #
NA - Nord America 1.612
EU - Europa 441
AS - Asia 333
OC - Oceania 3
AF - Africa 1
Totale 2.390
Nazione #
US - Stati Uniti d'America 1.610
CN - Cina 209
UA - Ucraina 114
IT - Italia 85
DE - Germania 80
TR - Turchia 72
GB - Regno Unito 49
SE - Svezia 41
SG - Singapore 37
FI - Finlandia 29
PL - Polonia 20
BE - Belgio 12
CZ - Repubblica Ceca 5
VN - Vietnam 4
IL - Israele 3
AU - Australia 2
CA - Canada 2
FR - Francia 2
ID - Indonesia 2
JP - Giappone 2
BD - Bangladesh 1
CH - Svizzera 1
EG - Egitto 1
IE - Irlanda 1
IQ - Iraq 1
IR - Iran 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 2.390
Città #
Woodbridge 236
Chandler 196
Fairfield 150
Jacksonville 146
Ann Arbor 140
Ashburn 88
Wilmington 75
Houston 72
Seattle 60
Beijing 54
Cambridge 45
Izmir 44
Nanjing 44
Ferrara 30
Shanghai 30
Princeton 29
Boardman 23
New York 21
Warsaw 20
Singapore 18
Dearborn 17
Milan 16
Nanchang 15
Shenyang 14
Changsha 13
San Diego 13
Brussels 12
Bremen 8
Mountain View 8
Des Moines 7
Hebei 6
Monmouth Junction 6
Norwalk 6
Redwood City 6
Tianjin 6
Auburn Hills 5
Brno 5
Jiaxing 5
Jinan 5
Dong Ket 4
Guangzhou 4
Kunming 4
London 4
Düsseldorf 3
Orange 3
Sheffield 3
Tel Aviv 3
Augusta 2
Bologna 2
Hefei 2
Helsinki 2
Inzago 2
Jakarta 2
Leawood 2
Portici 2
San Mateo 2
Yellow Springs 2
Abano Terme 1
Addison 1
Anzola Dell'emilia 1
Apo 1
Ardabil 1
Asahi 1
Auckland 1
Bangkok 1
Boxborough 1
Brierley Hill 1
Cairo 1
Chicago 1
Dortmund 1
Dublin 1
Emden 1
Falls Church 1
Forest City 1
Frankfurt am Main 1
Genoa 1
Haikou 1
Imola 1
Jesi 1
Leipzig 1
Los Angeles 1
Melbourne 1
Memphis 1
Milford 1
Montegrotto Terme 1
Munich 1
Ningbo 1
Oslo 1
Ottawa 1
Paris 1
Perth 1
Poulsbo 1
Pregassona 1
San Francisco 1
Taizhou 1
Toronto 1
Washington 1
Zoppola 1
Totale 1.783
Nome #
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 170
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 159
Coexistence of antithrombin deficiency, factor V Leiden and hyperhomocysteinemia in a thrombotic family. 125
Coagulation factor XIIIA (F13A1): Novel perspectives in treatment and pharmacogenetics 123
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 119
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 115
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 105
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 95
Replacement of the Y450 (c234) phenyl ring in the carboxyl-terminal region of coagulation factor IX causes pleiotropic effects on secretion and enzyme activity 93
null 91
C677T/A1298C MTHFR Gene Mutations, Homocysteine, Folate Levels and MTHFR Activity, in Normal Subjects and Cases with Myocardial Infarction 87
null 80
Una "rete" per proteggere il cuore. (FAR 2013) 79
Factor XIII-A Gene Mutation (Val34Leu) and Arterial Vascular Disease 70
A modified functional Global test to measure PC, PS activities and the APC-Resistance phenotype. 70
FXIII Levels in Myocardial Infarction: a Potential Novel Prognostic Biomarker? 67
Resistance to activated protein C and low levels of protein S activity in nine thrombophilic families: a correct diagnosis. 66
Dihydrofolate reductase (DHFR) 19-bp ins/del polymorphism and methylenetetrahydrofolate reductase (MTHFR) C677T in coronary heart disease patients: potential intracellular folate unbalancing. 65
Effect of factor XIII Val34Leu polymorphism on plasma clot formation: crosslinking functions and clot longevity properties. 64
Factor V Levels in a Cohort of Patients Eligible for Oral Anticoagulant Therapy. 63
Coexistence of antitrhombin deficency, factor V Leiden and hereditary hyperhomocyst(e)inemia in a thrombotic family. 62
Thrombotic risk in thalassemic patients. 59
Low folate levels and thermolabile MTHFR as primary determinant of mild Hyperhomocysteinemia in normal and thromboembolic subjects. 51
Differente risposta alla Proteina C attivata della muatazione R506Q del fattore V della coagulazione (FV Leiden) in due generazioni della stessa famiglia. 51
MTHFR C677T/A1298C, MS A2756G and MTRR A66G Gene Polymorphisms: Effects on Homocysteine Levels and Risk of Miocardial Infarction 50
Low Sensitivity to Endogenous Activated Protein C in Protein S Deficient Subjects Reflects a Reduction in the Thrombotic Risk 46
Determinazione dell’anticoagulante lupico (LAC) con un metodo al caolino automatizzato. 45
null 42
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 39
Rescue of coagulation factor VII mRNA processing and protein function by engineered U1+5A snRNA 30
The G to T Point Mutation (Val34Leu) in the Factor XIII-A Subunit Gene in Venous Leg Ulcers 28
Different anticoagulant response to activated protein C (APC-test) and to Agkistrodon Contortix Venom (ACV-test) in a family with FV-R506Q substitution 23
Totale 2.432
Categoria #
all - tutte 9.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020489 91 18 11 61 34 67 40 40 32 54 35 6
2020/2021352 34 19 7 37 11 32 27 42 12 60 56 15
2021/2022272 7 24 9 22 13 8 14 20 3 29 36 87
2022/2023401 37 46 7 58 65 52 21 35 45 1 18 16
2023/2024171 15 17 6 2 17 35 11 25 7 0 1 35
2024/202520 20 0 0 0 0 0 0 0 0 0 0 0
Totale 2.432